ZYMEWORKS INC. - COMMON STOCK

Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results

01 أغسطس 2024 16:05:01 بحسب Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

30 يوليو 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer

25 يوليو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate

22 يوليو 2024 06:00:38 بحسب Nasdaq GlobeNewswire

Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024

11 يوليو 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers

17 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer

10 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

28 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results

02 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

30 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

11 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

08 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

28 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

27 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results

06 مارس 2024 16:09:10 بحسب Nasdaq GlobeNewswire

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting

05 مارس 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

27 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call

14 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

08 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

31 يناير 2024 06:00:00 بحسب Nasdaq GlobeNewswire